IMIBIO-SL   20937
INSTITUTO MULTIDISCIPLINARIO DE INVESTIGACIONES BIOLOGICAS DE SAN LUIS
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
STRUCTURAL BIOLOGY OF T. cruzi BROMODOMAIN FACTORS AS POTENTIAL TARGET FOR DRUG DESING
Autor/es:
GÓMEZ BARROSO JA, JEREZ B, VILLANOVA V, SERRA E, AGUILAR CF.
Lugar:
Mendoza
Reunión:
Congreso; XXVI Annual Scientific Meeting of Cuyo Biology Society; 2008
Institución organizadora:
Sociedad de Biología de Cuyo
Resumen:
STRUCTURAL BIOLOGY OF T. cruzi BROMODOMAIN
FACTORS AS POTENTIAL TARGET FOR DRUG DESING
Gómez Barroso JA, Jerez B, Villanova V, Serra E, Aguilar CF.
Lab de Biol Mol Estructural, Univ Nac de San Luis, San Luis 5700.
E-mail: jagomez@unsl.edu.ar
Trypanosoma cruzi is the etiologic agent of Chagas disease. Th
objective of our work is the resolution by X-ray crystallography o
the three-dimensional structure of T. cruzi bromodomain facto proteins
as a first step for rational drug design based on the structure
The main objective of the Chagas´ Disease Research Network is th
search for protein targets in metabolic routes absent in the human
host and common in trypanosomatids. The T. cruzi proteins studied
in this work are three bromodomain factors: TcBDF1, TcBDF2
and TcBDF3. They are expressed in E. coli as fusion proteins with
N terminal His-tag. We have overexpressed, purified and solubilized
these proteins for crystallization and other structural assays
Refolding assays was realized by TcBFD3. We have carried ou
bioinformatic studies. These proteins were overexpressed and purified
in adequate amounts for crystallization assays and othe structural
studies. Preliminary structural and bioinformatic studie revealed
important properties which can be used for drug design.